Cathepsin H regulated by the thyroid hormone receptors associate with tumor invasion in human hepatoma cells

Oncogene

Volumn 30, Issue 17, 2011, Pages 2057-2069

  Wu, S M ^a   Huang, Y H ^b   Yeh, C T ^b   Tsai, M M ^a,c   Liao, C H ^a   Cheng, W L ^a   Chen, W J ^b   Lin, K H ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

cysteine proteases; hepatocellular carcinoma; migration; receptors

Indexed keywords

CATHEPSIN H; LIOTHYRONINE; MATRIX METALLOPROTEINASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEOTIDE; THYROID HORMONE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INVASION; CELL INVASION; CELL MIGRATION; CELL STRAIN HEPG2; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; ENZYME ACTIVATION; GENE CONTROL; GENE EXPRESSION; GENE LOCATION; GENE OVEREXPRESSION; HEPATOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SCID MOUSE; THYROIDECTOMY; UPREGULATION;

ANIMALS; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CATHEPSIN H; CELL MOVEMENT; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; MALE; MICE; NEOPLASM INVASIVENESS; PROMOTER REGIONS, GENETIC; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, THYROID HORMONE; RETINOID X RECEPTORS; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRIIODOTHYRONINE; UP-REGULATION;

MUS; RATTUS;

EID: 79955473609     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.585     Document Type: Article

References (52)

1. Ando S, Sarlis NJ, Krishnan J, Feng X, Refetoff S, Zhang MQ et al. (2001). Aberrant alternative splicing of thyroid hormone receptor in a TSH-secreting pituitary tumor is a mechanism for hormone resistance. Mol Endocrinol 15: 1529-1538. (Pubitemid 32826405)
2. Barrera-Hernandez G, Park KS, Dace A, Zhan Q, Cheng SY. (1999). Thyroid hormone-induced cell proliferation in GC cells is mediated by changes in G1 cyclin/cyclin-dependent kinase levels and activity. Endocrinology 140: 5267-5274.
3. Berdowska I. (2004). Cysteine proteases as disease markers. Clin Chim Acta 342: 41-69. (Pubitemid 38352913)
4. Chamba A, Neuberger J, Strain A, Hopkins J, Sheppard MC, Franklyn JA. (1996). Expression and function of thyroid hormone receptor variants in normal and chronically diseased human liver. J Clin Endocrinol Metab 81: 360-367. (Pubitemid 26035046)
5. Chen RN, Huang YH, Lin YC, Yeh CT, Liang Y, Chen SL et al. (2008a). Thyroid hormone promotes cell invasion through activa-tion of furin expression in human hepatoma cell lines. Endocrinology 149: 3817-3831.
6. Chen RN, Huang YH, Yeh CT, Liao CH, Lin KH. (2008b). Thyroid hormone receptors suppress pituitary tumor transforming gene 1 activity in hepatoma. Cancer Res 68: 1697-1706.
7. Chiloeches A, Sanchez-Pacheco A, Gil-Araujo B, Aranda A, Lasa M. (2008). Thyroid hormone-mediated activation of the ERK/dual specificity phosphatase 1 pathway augments the apoptosis of GH4C1 cells by down-regulating nuclear factor-kappaB activity. Mol Endocrinol 22: 2466-2480.
8. Davis FB, Tang HY, Shih A, Keating T, Lansing L, Hercbergs A et al. (2006). Acting via a cell surface receptor, thyroid hormone is a growth factor for glioma cells. Cancer Res 66: 7270-7275. (Pubitemid 44197708)
9. Del Re EC, Shuja S, Cai J, Murnane MJ. (2000). Alterations in cathepsin H activity and protein patterns in human colorectal carcinomas. Br J Cancer 82: 1317-1326. (Pubitemid 30145352)
10. Dickinson DP. (2002). Cysteine peptidases of mammals: their biological roles and potential effects in the oral cavity and other tissues in health and disease. Crit Rev Oral Biol Med 13: 238-275. (Pubitemid 34791209)
11. Gabrijelcic D, Svetic B, Spaic D, Skrk J, Budihna M, Dolenc I et al. (1992). Cathepsins B, H and L in human breast carcinoma. Eur J Clin Chem Clin Biochem 30: 69-74.
12. Gocheva V, Joyce JA. (2007). Cysteine cathepsins and the cutting edge of cancer invasion. Cell Cycle 6: 60-64. (Pubitemid 46173882)
13. Hall LC, Salazar EP, Kane SR, Liu N. (2008). Effects of thyroid hormones on human breast cancer cell proliferation. J Steroid Biochem Mol Biol 109: 57-66.
14. Hassan MM, Kaseb A, Li D, Patt YZ, Vauthey JN, Thomas MB et al. (2009). Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United States. Hepatology 49: 1563-1570.
15. Huang C, Jacobson K, Schaller MD. (2004). MAP kinases and cell migration. J Cell Sci 117: 4619-4628. (Pubitemid 39433429)
16. Huang YH, Lee CY, Tai PJ, Yen CC, Liao CY, Chen WJ et al. (2006). Indirect regulation of human dehydroepiandrosterone sulfotrans-ferase family 1A member 2 by thyroid hormones. Endocrinology 147: 2481-2489.
17. Huang YH, Liao CH, Chen RN, Liao CJ, Lin KH. (2010). Human testicular orphan receptor 4 enhances thyroid hormone receptor signaling. J Cell Physiol 222: 347-356.
18. Huang YH, Tsai MM, Lin KH. (2008). Thyroid hormone dependent regulation of target genes and their physiological significance. Chang Gung Med J 31: 325-334.
19. Joyce JA, Hanahan D. (2004). Multiple roles for cysteine cathepsins in cancer. Cell Cycle 3: 1516-1619.
20. Kos J, Stabuc B, Schweiger A, Krasovec M, Cimerman N, Kopitar-Jerala N et al. (1997). Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients. Clin Cancer Res 3: 1815-1822. (Pubitemid 27444722)
21. Kress E, Rezza A, Nadjar J, Samarut J, Plateroti M. (2009). The frizzled-related sFRP2 gene is a target of thyroid hormone receptor alpha1 and activates beta-catenin signaling in mouse intestine. J Biol Chem 284: 1234-1241.
22. Kress E, Skah S, Sirakov M, Nadjar J, Gadot N, Scoazec JY, et al. (2010). Cooperation between the thyroid hormone receptor TRalpha1 and the WNT pathway in the induction of intestinal tumorigenesis. Gastroenterology 138: 1863-1874.
23. Lazar MA. (1993). Thyroid hormone receptors: multiple forms, multiple possibilities. Endocr Rev 14: 184-193. (Pubitemid 23118416)
24. Liao CH, Yeh SC, Huang YH, Chen RN, Tsai MM, Chen WJ et al. (2010). Positive regulation of spondin 2 by thyroid hormone is associated with cell migration and invasion. Endocr Relat Cancer 17: 99-111.
25. Liao CS, Tai PJ, Huang YH, Chen RN, Wu SM, Kuo LW et al. (2009). Regulation of AKR1B1 by thyroid hormone and its receptors. Mol Cell Endocrinol 307: 109-117.
26. Lin KH, Shieh HY, Hsu HC. (2000). Negative regulation of the antimetastatic gene Nm23-H1 by thyroid hormone receptors. Endocrinology 141: 2540-2547.
27. Lin KH, Wu YH, Chen SL. (2001). Impaired interaction of mutant thyroid hormone receptors associated with human hepatocellular carcinoma with transcriptional coregulators. Endocrinology 142: 653-662.
28. Martinez-Iglesias O, Garcia-Silva S, Regadera J, Aranda A. (2009). Hypothyroidism enhances tumor invasiveness and metastasis development. PLoS One 4: e6428.
29. Mohamed MM, Sloane BF. (2006). Cysteine cathepsins: multifunc-tional enzymes in cancer. Nat Rev Cancer 6: 764-775. (Pubitemid 44450465)
30. Nelson D, Ganss R. (2006). Tumor growth or regression: powered by inflammation. J Leukoc Biol 80: 685-690. (Pubitemid 44835882)
31. Palermo C, Joyce JA. (2008). Cysteine cathepsin proteases as pharmacological targets in cancer. Trends Pharmacol Sci 29: 22-28.
32. Plateroti M, Kress E, Mori JI, Samarut J. (2006). Thyroid hormone receptor alpha1 directly controls transcription of the beta-catenin gene in intestinal epithelial cells. Mol Cell Biol 26: 3204-3214.
33. Puzianowska-Kuznicka M, Krystyniak A, Madej A, Cheng SY, Nauman J. (2002). Functionally impaired TR mutants are present in thyroid papillary cancer. J Clin Endocrinol Metab 87: 1120-1128. (Pubitemid 36121076)
34. Rosen MD, Privalsky ML. (2009). Thyroid hormone receptor mutations found in renal clear cell carcinomas alter corepressor release and reveal helix 12 as key determinant of corepressor specificity. Mol Endocrinol 23: 1183-1192.
35. Samuels HH, Stanley F, Casanova J. (1979). Depletion of L-3,5,3'-triiodothyronine and L-thyroxine in euthyroid calf serum for use in cell culture studies of the action of thyroid hormone. Endocrinology 105: 80-85. (Pubitemid 9199127)
36. Schraufstatter IU, Trieu K, Zhao M, Rose DM, Terkeltaub RA, Burger M. (2003). IL-8-mediated cell migration in endothelial cells depends on cathepsin B activity and transactivation of the epidermal growth factor receptor. J Immunol 171: 6714-6722. (Pubitemid 37532104)
37. Shih CH, Chen SL, Yen CC, Huang YH, Chen CD, Lee YS et al. (2004). Thyroid hormone receptor-dependent transcriptional regulation of fibrinogen and coagulation proteins. Endocrinology 145: 2804-2814.
38. Sivaparvathi M, Sawaya R, Gokaslan ZL, Chintala SK, Rao JS. (1996). Expression and the role of cathepsin H in human glioma progression and invasion. Cancer Lett 104: 121-126. (Pubitemid 26154022)
39. Suzuki H, Willingham MC, Cheng SY. (2002). Mice with a mutation in the thyroid hormone receptor beta gene spontaneously develop thyroid carcinoma: a mouse model of thyroid carcinogenesis. Thyroid 12: 963-969. (Pubitemid 35404130)
40. Teranishi S, Kimura K, Nishida T. (2009). Role of formation of an ERK-FAK-paxillin complex in migration of human corneal epithelial cells during wound closure in vitro. Invest Ophthalmol Vis Sci 50: 5646-5652.
41. Thormeyer D, Baniahmad A. (1999). The v-erbA oncogene (review). Int J Mol Med 4: 351-358.
42. Tsui KH, Hsieh WC, Lin MH, Chang PL, Juang HH. (2008). Triiodothyronine modulates cell proliferation of human prostatic carcinoma cells by downregulation of the B-cell translocation gene 2. Prostate 68: 610-619.
43. Tsushima H, Ueki A, Matsuoka Y, Mihara H, Hopsu-Havu VK. (1991). Characterization of a cathepsin-H-like enzyme from a human melanoma cell line. Int J Cancer 48: 726-732.
44. Turk B, Turk D, Turk V. (2000). Lysosomal cysteine proteases: more than scavengers. Biochim Biophys Acta 1477: 98-111. (Pubitemid 30119895)
45. Turk V, Turk B, Turk D. (2001). Lysosomal cysteine proteases: facts and opportunities. EMBO J 20: 4629-4633. (Pubitemid 32848615)
46. Wilson TJ, Singh RK. (2008). Proteases as modulators of tumor-stromal interaction: primary tumors to bone metastases. Biochim Biophys Acta 1785: 85-95.
47. Wu SM, Huang YH, Lu YH, Chien LF, Yeh CT, Tsai MM, et al. (2010). Thyroid hormone receptor-mediated regulation of the methionine adenosyltransferase 1 gene is associated with cell invasion in hepatoma cell lines. Cell Mol Life Sci 67: 1831-1843.
48. Yang H, Yuan P, Wu V, Tache Y. (1999). Feedback regulation of thyrotropin-releasing hormone gene expression by thyroid hormone in the caudal raphe nuclei in rats. Endocrinology 140: 43-49. (Pubitemid 29011139)
49. Yang L, Moses HL. (2008). Transforming growth factor beta: tumor suppressor or promoter? Are host immune cells the answer? Cancer Res 68: 9107-9111.
50. Yen PM. (2001). Physiological and molecular basis of thyroid hormone action. Physiol Rev 81: 1097-1142. (Pubitemid 32606667)
51. Yen PM, Ikeda M, Brubaker JH, Forgione M, Sugawara A, Chin WW. (1994). Roles of v-erbA homodimers and heterodimers in mediating dominant negative activity by v-erbA. J Biol Chem 269: 903-909. (Pubitemid 24032462)
52. Zhu XG, Zhao L, Willingham MC, Cheng SY. (2010). Thyroid hormone receptors are tumor suppressors in a mouse model of metastatic follicular thyroid carcinoma. Oncogene 29: 1909-1919.